Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-19 4:59 pm Purchase | 2021-08-10 | 13G | Tango Therapeutics, Inc. TNGX | Casdin Capital, LLC | 5,487,910 6.300% | 5,487,910 (New Position) | Filing History |
| 2021-08-09 2:06 pm Purchase | 2021-07-29 | 13D | Tenaya Therapeutics, Inc. TNYA | Casdin Capital, LLC | 3,586,818 8.700% | 3,586,818 (New Position) | Filing History |
| 2021-08-03 5:16 pm Purchase | 2021-07-29 | 13G | MaxCyte, Inc. MXCT | Casdin Capital, LLC | 13,971,334 14.200% | 13,971,334 (New Position) | Filing History |
| 2021-07-29 2:11 pm Purchase | 2021-06-17 | 13D | Century Therapeutics, Inc. IPSC | Casdin Capital, LLC | 3,246,124 5.900% | 3,246,124 (New Position) | Filing History |
| 2021-07-29 1:12 pm Purchase | 2021-07-21 | 13D | Absci Corporation ABSI | Casdin Capital, LLC | 7,718,593 8.500% | 7,718,593 (New Position) | Filing History |
| 2021-06-23 11:38 am Purchase | 2021-06-17 | 13G | Verve Therapeutics, Inc. VERV | Casdin Capital, LLC | 3,038,167 6.600% | 3,038,167 (New Position) | Filing History |
| 2021-02-11 10:28 am Sale | 2020-12-31 | 13G | GRITSTONE BIO INC GRTSQ | Casdin Capital, LLC | 0 0.000% | -2,160,000 (Position Closed) | Filing History |
| 2021-02-11 10:25 am Purchase | 2020-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Casdin Capital, LLC | 3,346,035 6.930% | 247,913 (+8.00%) | Filing History |
| 2021-02-11 10:23 am Purchase | 2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC | Casdin Capital, LLC | 1,241,176 4.520% | 1,891 (+0.15%) | Filing History |
| 2021-02-11 10:19 am Purchase | 2020-12-31 | 13G | Invitae Corporation NVTAQ | Casdin Capital, LLC | 12,298,038 6.370% | 3,264,095 (+36.13%) | Filing History |
| 2021-02-11 10:17 am Sale | 2020-12-31 | 13G | DermTech, Inc. DMTKQ | Casdin Capital, LLC | 1,370,000 6.990% | -58,571 (-4.10%) | Filing History |
| 2021-02-11 10:12 am Sale | 2020-12-31 | 13G | Codexis, Inc. CDXS | Casdin Capital, LLC | 4,330,000 6.820% | -743,780 (-14.66%) | Filing History |
| 2020-11-27 5:21 pm Purchase | 2020-11-24 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 7,440,107 22.700% | 3,066,774 (+70.12%) | Filing History |
| 2020-06-01 1:14 pm Purchase | 2020-05-27 | 13G | DermTech, Inc. DMTKQ | Casdin Capital, LLC | 1,428,571 7.900% | 1,428,571 (New Position) | Filing History |
| 2020-05-18 6:15 pm Purchase | 2020-05-14 | 13G | BioLife Solutions, Inc. BLFS | Casdin Capital, LLC | 4,373,333 18.200% | 1,904,762 (+77.16%) | Filing History |
| 2020-05-18 4:18 pm Sale | 2020-05-12 | 13D | GENMARK DIAGNOSTICS INC GNMK | Casdin Capital, LLC | 2,555,000 4.100% | -810,000 (-24.07%) | Filing History |